| |
| |
|
| Insider
Information: |
Tananbaum James B. |
| Relationship: |
10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
1,064,512 |
|
|
Indirect Shares
|
33,413,451 |
|
|
| Direct
Value |
$19,999,397 |
|
|
|
Indirect Value
|
$436,713,163 |
|
|
| Total
Shares |
34,477,963 |
|
|
| Total
Value |
$456,712,560 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
9
|
1
|
|
Stock
price went up :
|
8
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
8.0
|
-1.0
|
| Percentage
Gain/Loss : |
 36.0%
|
 -23.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aimmune Therapeutics, Inc. |
AIMT |
10% Owner |
2015-08-11 |
0 |
2016-08-18 |
4,902,920 |
Premium* |
|
|
Aerie Pharmaceuticals Inc |
AERI |
10% Owner |
2016-07-22 |
0 |
2020-02-27 |
1,229,633 |
Premium* |
|
|
10x Genomics, Inc. |
TXG |
10% Owner |
2019-09-12 |
0 |
2020-05-13 |
2,677,383 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
Director |
2020-08-14 |
441,500 |
2021-02-05 |
3,370,250 |
Premium* |
|
|
Kinnate Biopharma Inc. |
KNTE |
|
2020-12-07 |
0 |
2024-04-03 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
|
0 |
2021-11-01 |
4,665,553 |
Premium* |
|
|
Pardes Biosciences Ord Shs |
PRDS |
Director, 10% Owner |
2021-02-19 |
602,500 |
2023-04-05 |
13,583,762 |
Premium* |
|
|
Highcape Capital Acquisition Corp. |
QSI |
Director |
2021-06-11 |
20,512 |
2021-06-10 |
1,598,125 |
Premium* |
|
|
Theseus Pharmaceuticals, Inc. |
THRX |
10% Owner |
|
0 |
2023-07-17 |
1,385,825 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2016-07-22 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
3,370,598 |
|
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2016-07-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,120,598 |
|
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
10% Owner |
– – • |
2016-08-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,902,920 |
|
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2017-05-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,643,191 |
|
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-08-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,493,636 |
|
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
– – • |
2021-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,612,181 |
|
% |
|
| THRX |
Theseus Pharmaceuticals, ... |
10% Owner |
– – • |
2022-06-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,294,621 |
|
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-08-21 |
4 |
B |
$23.25 |
$26,807 |
I/I |
1,153 |
2,205,477 |
1.5 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-08-19 |
4 |
B |
$23.34 |
$89,789 |
I/I |
3,847 |
2,154,324 |
1.5 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-11-26 |
4 |
OE |
$30.00 |
$132,000 |
I/I |
4,400 |
1,445,900 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-11-14 |
4 |
OE |
$30.00 |
$171,000 |
I/I |
5,700 |
1,421,600 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-08-22 |
4 |
B |
$23.68 |
$158,656 |
I/I |
6,700 |
2,212,177 |
1.5 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
– – • |
2021-11-01 |
4 |
A |
$0.00 |
$0 |
I/I |
8,276 |
8,276 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-11-07 |
4 |
OE |
$30.00 |
$450,000 |
I/I |
15,000 |
1,415,900 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-09-05 |
4 |
B |
$18.42 |
$289,194 |
I/I |
15,700 |
2,350,477 |
1.5 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-11-15 |
4 |
OE |
$30.00 |
$597,000 |
I/I |
19,900 |
1,441,500 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2017-05-26 |
4 |
S |
$55.95 |
$1,119,000 |
I/I |
(20,000) |
1,950,477 |
0 |
- |
|
| QSI |
Highcape Capital Acquisit... |
Director |
– • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
20,512 |
20,512 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-08-30 |
4 |
B |
$21.36 |
$534,000 |
I/I |
25,000 |
2,275,477 |
1.5 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
10% Owner |
– – • |
2015-08-24 |
4 |
B |
$19.65 |
$500,900 |
I/I |
25,485 |
355,020 |
1.5 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-12-03 |
4 |
OE |
$30.00 |
$798,000 |
I/I |
26,600 |
1,472,500 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-12-20 |
4 |
OE |
$30.00 |
$867,000 |
I/I |
28,900 |
1,501,400 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-08-23 |
4 |
B |
$23.42 |
$896,986 |
I/I |
38,300 |
2,250,477 |
1.5 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2016-10-06 |
4 |
S |
$40.34 |
$2,016,995 |
I/I |
(50,000) |
1,672,697 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2019-08-20 |
4 |
B |
$23.21 |
$1,160,500 |
I/I |
50,000 |
2,204,324 |
1.5 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
